| Identification | Back Directory | [Name]
3-Hydroxypyruvic Acid Lithium Salt | [CAS]
209728-15-4 | [Synonyms]
Hydroxypyruvic acid lithium hydrate
β-Hydroxypyruvic acid lithium hydrate
3-Hydroxypyruvic acid lithium hydrate | [Molecular Formula]
C3H7LiO5 | [MOL File]
209728-15-4.mol | [Molecular Weight]
130.02 |
| Hazard Information | Back Directory | [Uses]
3-Hydroxypyruvic Acid Lithium Salt, can be used for the rapid and reliable measurement of transketolase (TK) activity, via pH-based high-throughput assay method. It can also be used for the preparation of Fagomine, a novel naturally occurring glucose analog. | [in vivo]
Hydroxypyruvic acid (lithium hydrate) (intravenous injection; 100 mg/ml; slowly over 10 min) increases the 5-h urinary oxalate and glycolate excretion to 0.68% (6.56 μmol) and 0.53% (5.10 μmol) in control rats, in addition, it increases to 2.43% (23.36 μmol) and 0.79% (7.59 μmol) of the dose in the vitamin-B6-deficient rats[1]. | [IC 50]
Human Endogenous Metabolite |
|
| Company Name: |
MedChemExpress
|
| Tel: |
021-58955995 |
| Website: |
www.medchemexpress.com |
|